4DMedical (ASX:4DX) Capex-to-Revenue : 0.24 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is 4DMedical Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

4DMedical's Capital Expenditure for the six months ended in Dec. 2023 was A$-0.19 Mil. Its Revenue for the six months ended in Dec. 2023 was A$0.79 Mil.

Hence, 4DMedical's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.24.

4DMedical Capex-to-Revenue Historical Data

The historical data trend for 4DMedical's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4DMedical Capex-to-Revenue Chart

4DMedical Annual Data

Trend

Jun21

Jun22

Jun23

Capex-to-Revenue

3.34

2.92

2.59

4DMedical Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Capex-to-Revenue	Get a 7-Day Free Trial			14.27	0.93	0.60	-	0.24

Competitive Comparison of 4DMedical's Capex-to-Revenue

For the Medical Devices subindustry, 4DMedical's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4DMedical's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where 4DMedical's Capex-to-Revenue falls into.

4DMedical Capex-to-Revenue Calculation

4DMedical's Capex-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-0.731)	/	0.282
	=	2.59

4DMedical's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-0.186)	/	0.793
	=	0.23

4DMedical (ASX:4DX) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

4DMedical Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of 4DMedical's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

4DMedical (ASX:4DX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 4DMedical Ltd (ASX:4DX) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

FDMDF:USA

Address

700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053

Website

https://www.4dmedical.com

4DMedical Ltd is a company whose principal activities is medical research technology and the development of a non?invasive respiratory imaging solution using four?dimensional imaging. The four-dimensional lung imaging technology utilises mathematics models and algorithms to convert X-ray scans into quantitative data which helps the physicians to manage patients with respiratory diseases and diseases of the lung.

4DMedical (ASX:4DX) Headlines

No Headlines